ARTICLE | Clinical News
Smart Anti-tac humanized antibody: A Phase I trial
March 21, 1994 8:00 AM UTC
Protein Design Labs Inc. (PDLI), Mountain View, Calif. Product: Smart Anti-tac humanized antibody to the interleukin-2 receptor on activated T cells and certain blood cancers Indication: Graft versus...